PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
PepGen Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.70+0.10 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $186.85M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$2.19 (−44.79%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $186.85M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.56
- Dividend yield
- –
- Free cash flow yield
- -37.18%
Fundamentals
- Net income
- -$71.94M
- EPS, diluted
- -$1.31
- Free cash flow
- -$69.46M
- Book value per share
- $1.73
- Diluted shares
- 69M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Operating income
-$76.24M
Net income
-$71.94M
EPS, diluted
-$1.31
Free cash flow
-$69.46M
Reported periodTrailing twelve months